Abstract 2095P
Background
Cancer-related fatigue (CRF) is a significant and frequent problem among cancer patients. There is no gold standard. However, ESMO CPGL 2020 recommended multimodal interventions, CRF is underdiagnosed, undertreated and underdocumented. In this study, we evaluated cancer rehabilitation program including education, physical activity and emotional support.
Methods
Cancer rehabilitation program includes: patients and family education, physical activity (aerobic exercise), water- therapy, yoga, behavioural therapy, relaxation, art, music-therapy, proteinrich nutrition, social support. The Five-time-sit-to-stand test, Hand-Grip-Strength, 6 min walking test, Brief fatigue inventory, Hospital anxiety and Depression scale were used. Descriptive statistics and t-tests.
Results
Participants were 112 patients (48y [29-75]), 60.7% women and 39.2% men. The primary cancer was 26.7 % breast, 16.9% gasrtoesophageal 33.6% colorectal, 16.8% lung, 5.96% pancreatobiliary. Before rehabilitation: the Five-time-sit-to-stand test 10.2 sec (4.5-28.1), Hand-Grip-Strength 28.4 kg, 6 min walking test 482 meters (49,631), Brief fatigue inventory 45 (0-75), Fatique 8/10 (0,10), Cognitive 6, Emotional 4, Physical 6, QoL 4 (0-10). HADS 8 (0, 18). After rehabilitation: the Five-time-sit-to-stand test 5.7 sec (-50%), Hand-Grip-Strength 39.2 kg, 6 min walking test 585 meters (62,822), Brief fatigue inventory 25 (0-58), Fatique 3/10 (0,10), Cognitive 3, Emotional 1, Physical 4, QoL 7 (0-10). HADS 4 (0, 18).
Conclusions
Cancer rehabilitation program including different types of interventions is effective in treating cancer related-fatigue.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2096P - Morphine titration with intravenous patient-controlled analgesia for severe cancer pain (Mr.TIPS)
Presenter: Seok Jae Huh
Session: Poster session 06
2097P - Incidence, risk factors (RFs) and management of oral mucositis (OM) in patients (pts) treated with a fluoropyrimidines (FP)-based therapy (tp): A retrospective, monocentric experience
Presenter: Fiorella Manfredi
Session: Poster session 06
2098P - The impact of concomitant use of non-opioid analgesics and immune checkpoint inhibitors on survival in lung cancer patients: A Hong Kong population-based cohort study
Presenter: Zheng-Hao Ye
Session: Poster session 06
2099P - The role of ambulatory blood pressure measurement in TKI-induced arterial hypertension diagnosis
Presenter: Elina Khachaturian
Session: Poster session 06
2100P - An exploratory study of the efficacy and safety of hetrombopag in the treatment of thrombocytopenia induced by concurrent or sequential chemoradiotherapy
Presenter: Jun Wang
Session: Poster session 06
2101P - Bleeding Induced by ANtiCAncer drugs (BIANCA) used breast cancer
Presenter: Nicolas Janus
Session: Poster session 06
2102P - Changes in opioid usage after intrathecal morphine pump implantation in patients with terminal cancer (pilot study)
Presenter: Eun Joo Choi
Session: Poster session 06
2103P - Phase Ib, international, dose-escalation study to evaluate the safety, pharmacokinetics (PK) and efficacy of ST-617 a dithiolethione, for the attenuation of oral mucositis (OM) in patients receiving chemoradiation (CRT) for head & neck (H&N) cancer
Presenter: Daniel Osei-Fofie
Session: Poster session 06
2104P - Prevention of taxane chemotherapy induced nail changes and peripheral neuropathy by application of extremity cooling: A prospective single center study with intrapatient comparison
Presenter: Kristen Johnson
Session: Poster session 06
2105P - Prophylactic role of a postbiotic microbiota-stabilizer on abemaciclib-induced diarrhea in breast cancer patients: A pilot application study
Presenter: Rita De Sanctis
Session: Poster session 06